Crown Reserve Acquisition Corp. I and Carvix, Inc. Announce Definitive Business Combination Agreement

Core Viewpoint - The business combination between Crown Reserve Acquisition Corp. I and Carvix, Inc. values Carvix at an implied enterprise value of $1.0 billion, with the combined company expected to trade on Nasdaq [1][5]. Transaction Highlights - The transaction involves a merger where a wholly owned subsidiary of Crown Reserve will merge with Carvix, making Carvix a wholly owned subsidiary of Crown Reserve [1]. - Existing Carvix stockholders will receive Crown Reserve common stock in an all-stock transaction based on a reference value of $10.00 per share [5]. - Crown Reserve aims to raise a minimum of $80.0 million in PIPE financing and a committed equity line of credit of no less than $20.0 million [5]. Management Commentary - Carvix's CEO emphasized the company's strategy of leveraging technology to consolidate the automotive services industry, aiming for operational efficiency and scalable growth [3]. - Crown Reserve's Managing Member expressed confidence in Carvix's differentiated platform and the potential for long-term shareholder value [3]. Governance and Structure - The post-closing board will consist of five members, with four nominated by Carvix and one by Crown Reserve, including independent directors mutually agreed upon [5]. - Carvix's existing management team will continue to lead the combined company after the merger [5]. Financial Considerations - The transaction includes an earnout consideration where certain Carvix stockholders may receive up to 50,000,100 additional shares of Crown Reserve common stock over a four-year period, contingent on revenue and EBITDA targets [5]. - The transaction is structured to qualify as a tax-free reorganization under U.S. federal income tax laws [5]. Closing Conditions - The business combination is subject to customary closing conditions, including shareholder approvals and the effectiveness of a registration statement with the SEC [6]. - Key Carvix stockholders have committed to vote in favor of the transaction through a Stockholder Support Agreement [6].